Scientists Uncover Molecular Mechanism Behind Statin-Induced Muscle Pain, Paving the Way for Safer Cardiovascular Medications
Statins stand among the most vital and widely prescribed medications used in modern medicine to prevent cardiovascular disease. By effectively lowering blood cholesterol levels, these drugs have helped save millions…
Researchers Uncover the Molecular Mechanism Behind Statin-Induced Muscle Pain, Opening the Door to Safer Heart Medications
Statins stand firmly among the most vital pharmaceutical interventions in modern medicine, playing an indispensable role in the global prevention of cardiovascular disease. By effectively lowering low-density lipoprotein cholesterol, these…
Rutgers Study Links Popular Diabetes and Weight Loss Medications to Rare Vision Risk
A comprehensive and large-scale study led by researchers at Rutgers University has identified a potential and concerning vision risk associated with some of the most widely used diabetes and weight…
Beyond Weight Loss: Popular GLP-1 Medications Linked to Unexpected Nail, Hair, and Scalp Issues in Multinational Study
Popular GLP-1 receptor agonist medications—widely prescribed for weight management and type 2 diabetes under brand names such as Ozempic, Wegovy, Mounjaro, Zepbound, Victoza, and Trulicity—have been linked to an unexpected…
Multinational Study Links Popular GLP-1 Medications to Unexpected Fingernail, Hair, and Scalp Issues
Popular GLP-1 receptor agonist medications used widely for weight loss management and type 2 diabetes—including well-known brand names such as Ozempic, Wegovy, Mounjaro, Zepbound, Victoza, and Trulicity—have been linked to…
New Multinational Study Links Popular GLP-1 Medications to Unexpected Nail, Hair, and Scalp Issues
Popular GLP-1 receptor agonist medications—widely prescribed for weight management and type 2 diabetes under brand names such as Ozempic, Wegovy, Mounjaro, Zepbound, Victoza, and Trulicity—have been linked to an unexpected…
Navigating a Quiet Revolution: Why Most ADHD Patients Should Stick With What Works Despite a Wave of New Medications
For nearly two decades, clinicians treating Attention-Deficit/Hyperactivity Disorder in the United States lived through a prolonged period of formulation recycling. Pharmaceutical companies routinely took established molecules—primarily amphetamines and methylphenidate—and repackaged…